Aedes albopictus
Mosquitoes, Yucatan Peninsula, Mexico
To the Editor: We collected Asian tiger mosquitoes, Aedes albopictus (Skuse), in Cancun in the Yucatan Peninsula of Mexico in September 2011. This mosquito is a nuisance biter of humans and a vector of numerous arboviruses, including those causing dengue, yellow fever, and chikungunya (1) .
Ae. albopictus mosquitoes, which are native to Southeast Asia, emerged in the continental United States in 1985 and thereafter spread rapidly across the southeastern United States and into northern Mexico (2, 3) . These mosquitoes have also been found in the states of Tamaulipas, Coahuila, and Nuevo Leon in northern Mexico, Chiapas in southern Mexico, and south of Mexico in Guatemala and Belize (3) (4) (5) (6) (7) (8) (9) . These fi ndings are now complemented by our collection of Ae. albopictus mosquitoes from Cancun in Quintana Roo State, which with Yucatan and Campeche States compose the Yucatan Peninsula. A previous study of the mosquito fauna of Quintana Roo conducted in 2006 did not report any Ae. albopictus mosquitoes (10) .
During September 2011, Ae. albopictus mosquitoes were collected from a cemetery in Cancun, which is located in the eastern part of the Yucatan Peninsula (21°8.53′Ν, 86°52.79′W) (Figure) . The collection location was shaded by trees. Water in containers from which larvae were collected had an average temperature of 24.5°C and a pH of 8.5. The larval collection included ≈30 specimens of different developmental stages that were collected from vases and other artifi cial containers in the cemetery. To the Editor: Pulmonary nontuberculous mycobacteria (NTM) diseases share clinical signs with tuberculosis (TB), causing a clinical dilemma with regard to therapy for patients with these diseases (1). In the past 30 years (post-AIDS era), NTM have increasingly been associated with pulmonary diseases in humans (2) . Recent studies in urban areas of the People's Republic of China have shown that the prevalence of NTM (isolation rate of NTM among all mycobacteria) is increasing; for example, prevalence in Shanghai increased from 4.26% in 2005 to 6.38% in 2008 (3). To investigate NTM prevalence in rural areas of China, we evaluated the NTM isolation rates, species distribution, and drug-resistance profi les through a population-based TB sentinel surveillance study in Shandong Province, the second largest province in China. The study protocol was approved by the Institutional Review Board of Shandong Provincial Chest Hospital (Jinan, Shandong, China).
Clinical samples were collected through the ongoing sentinel TB surveillance project, which fi rst began in 7 counties in Shandong Province in 2004 and expanded to 13 counties in 2008. Of the total surveillance population, rural populations accounted for ≈80%. Each sample collected in this study was identifi ed only by a unique participant number. Each surveillance site sent sputum samples from all patients with suspected TB to the TB Reference Laboratory of Shandong Provincial Chest Hospital for mycobacterial culture, drug-susceptibility testing, and species identifi cation.
From January 1, 2004, through December 31, 2009, Mycobacteria spp. were isolated from sputum specimens from 3,949 patients with suspected pulmonary TB. Of these patients, mean age ± SD was 48.7 ± 20.4 years (range 1-92 years), 74.6% were male, and 300 were being retreated for TB.
Identifi cation of Mycobacteria spp. was fi rst conducted by conventional biochemical testingp-nitrobenzoic acid and 2-thiophene carboxylic acid hydrazide testingfollowing a standard protocol (4) . Mycobacteria spp. were further identifi ed by 16S rRNA gene sequence analysis (MicroSeq ID Microbial Indentifi cation Software, version 2.0; Applied Biosystems, Foster City, CA, USA) to the species level as described (5) . Drug-susceptibility testing was performed according to standard procedures recommended by the World Health Organization, and quality control was conducted by inter-laboratory confi rmation testing by reference laboratories recognized by the World Health Organization in South Korea and in Hong Kong Special Administrative Region, China (6,7). The drug panel included 4 fi rstline anti-TB drugs: isoniazid, rifampin, streptomycin, and ethambutol.
The conventional biochemical testing of the 3,949 Mycobacteria spp. strains identifi ed 68 NTM strains, among which the 16s rRNA gene sequence analysis confi rmed 64 (1.6%) NTM strains and identifi ed 3 M. tuberculosis complex strains and 1 Nocardia glanders strain. Among the 64 NTM strains, 52 (81.2%) were M. intracellulare, 5 (7.8%) were M. kansasii, 3 (4.7%) were M. fortuitum, 2 (3.1%) were M. chelonae, 1 (1.6%) was M. gordonae, and 1 (1.6%) was M. scrofulaceum. The fi rstline anti-TB drug resistance rates of the 64 NTM strains were 100% for isoniazid, 98.4% for streptomycin, 78.1% for rifampin, and 51.6% for ethambutol (Table) . Among the 3,949 Mycobacteria spp. strains, 163 (4.1%) were resistant to at least isoniazid and
